| Literature DB >> 33024958 |
Olukolade George Shobo1, Anselm Okoro1, Magdalene Okolo1, Peter Longtoe1, Isaac Omale1, Endurance Ofiemu1, Jennifer Anyanti1.
Abstract
INTRODUCTION: Hypertensive disorders in pregnancy result in about 76,000 maternal deaths per year worldwide. Pre-eclampsia and eclampsia cause the most deaths. Interventions for managing these disorders are available in health facilities. We assess the effect of monitoring pregnant women's blood pressure (BP) in their homes using village health workers (VHWs) equipped with a BP-measuring device on hypertension in pregnancy, in a resource-poor setting. Also, we assess the VHWs' competence with the BP device, acceptability and appropriateness of the intervention, and factors that affect the implementation of the intervention.Entities:
Keywords: Community health workers; Hypertension in pregnancy; Primary healthcare; Resource-poor setting
Year: 2020 PMID: 33024958 PMCID: PMC7531128 DOI: 10.1186/s43058-020-00076-8
Source DB: PubMed Journal: Implement Sci Commun ISSN: 2662-2211
Fig. 1Communities VHWs cover in Gombe state
Community-level strategy for controlling hypertensive disorders in pregnancy using existing VHWs equipped with the Microlife VSA device
| Strategy | Engage government to take ownership and leadership of the initiative | Build local capacity to implement and scale up the BP intervention through existing community health programs | Monitor pregnant rural women’s blood pressure and refer cases to health facilities | Supportive supervision for VHWs |
|---|---|---|---|---|
| Actors | Investigators, implementers, and leadership of GSPHCDA | Consultant from teaching hospital, implementers | Village health workers | CHEW supervisors |
| Actions | Training workshop for: CHEWs further trained on supportive supervision On-the-field refresher trainings for VHWs 4 weeks after the first training | Identify pregnant women in the community Monitor their blood pressure during scheduled home visits Refer pregnant women with abnormal blood pressure to a health facility | Supportive supervision to VHWs 1st week post-training Meetings with VHWs at least once a month to assess progress with implementing the intervention and address data management issues | |
| Target | Government leadership and ownership of the intervention Readiness to use intervention’s result for decision-making | Pool of local experts with the capacity to scale up or the intervention in the state VHWs competent in assessing pregnant women’s BP and offering appropriate referral advice | Improve coverage and access to quality obstetric services in hard-to-reach communities | Continued delivery of quality community level obstetric services through VHWs |
| Temporality | Step 1 | Step 2 | Step 3 | Step 4 |
| Dose | As needed | Two-day 16-h training for 22 master trainers Two-day 12-h training for VHWs and CHEWs in clusters of 40 participants per class Two extra hours training for CHEWs Three hours on the field refresher training for VHWs in clusters of five to seven participants | At least two new home visits per week Revisits occur within 4 weeks of the first visit | 1st supportive supervision done in the 1st week post-training, then once for each VHW in the first month after the training Then once a week for VHWs identified as having challenges |
| Implementation outcomes addressed/affected | Adoption Capacity of government lead implementation Readiness of government to scale up the intervention | Capacity to assess pregnant women’s BP and refer abnormal cases to a health facility using the Microlife VSA device Capacity of CHEWs to ensure fidelity of the implementation strategy | Penetration and acceptability of the intervention Productivity of VHWs | Quality of services delivered Fidelity of the implementation strategy |
| Theoretical framework | Replicating effective programs (REP) framework for healthcare interventions | |||
Based on framework suggested by Proctor et al and Pinnock et al [31, 50]
Outcomes for implementation and intervention strategy
| Outcomes | Implementation strategy | Intervention strategy |
|---|---|---|
• Acceptability of the intervention • Appropriateness of the intervention | • Prevalence of hypertension in pregnancy | |
• Competency of VHWs with use of BP device | • Prevalence of isolated systolic hypertension in pregnancy • Prevalence of isolated diastolic hypertension in pregnancy |
Distribution of pregnant women assessed by VHWs
| Pregnant women reached with the intervention | %, | Test ( |
|---|---|---|
| Age = 25 years | NA | NA |
| SD = 5.5 years | ||
| Where they lived | ||
| Akko LGA | 40 | |
| Balanga LGA | 23 | |
| Gombe LGA | 37 | |
| When first visit occurred | ||
| February | 28 | |
| March | 26 | |
| April | 24 | |
| May | 22 | |
Characteristics of VHWs that implemented the intervention
| Application of CRADLE device on clients: VHWs observed | Frequency | Percent |
|---|---|---|
| Mean age = 30 years | NA | NA |
| SD = 7.2 years | ||
| Islamic studies | 1 | 0.2 |
| Primary | 43 | 10.4 |
| Junior secondary school certificate | 2 | 0.5 |
| Senior secondary school certificate | 317 | 76.9 |
| School of health technology | 41 | 10 |
| National college of education | 7 | 1.7 |
| Higher (tertiary) degree | 1 | 0.2 |
| Single | 10 | 2.4 |
| Married | 393 | 95.4 |
| Divorced | 1 | 0.2 |
| Widowed | 8 | 1.9 |
Result of paired observation of VHW-client interaction
| Variable | Period | VHWs competent with using the device | ||
|---|---|---|---|---|
| Baseline | 9 | 5–13 | < 0.001 | |
| End line | 95 | 90–99 | ||
| Baseline | 38 | 30–46 | < 0.001 | |
| End line | 95 | 90–98 | ||
| Baseline | 76 | 67–84 | < 0.001 | |
| End line | 99 | 98–100 | ||
| Baseline | 75 | 67–83 | < 0.001 | |
| End line | 99 | 98–100 | ||
| Baseline | 94 | 90–98 | 0.04 | |
| End line | 99 | 98–100 | ||
| Baseline | 84 | 78–90 | 0.04 | |
| End line | 93 | 89–97 | ||
| Baseline | 41 | 33–49 | < 0.001 | |
| End line | 82 | 75–88 | ||
Prevalence of blood pressure disorder in pregnancy and impact of intervention
| First visit %, | Second visit %, | Test ( | |
|---|---|---|---|
| | 1.5 (1.3–1.7) | 0.8 (0.6–1) | |
| | 3.8 (3.4–4.2) | 3.4 (3.0–3.8) | |
| | 8.5 (7.9–9.0) | 8.1 (7.5–8.7) | |